April 28, 2009
 Reckitt Benckiser, Inc., First Quarter 2009 Results
This is a report on first quarter 2009 results from Reckitt Benckiser, which markets Suboxone and Subutex, formulations of buprenorphine, through its pharmaceuticals division. The two medications are used for outpatient treatment of opioid addiction. The medications will lose patent protection in October 2009. This report discusses Reckitt Benckiser's plans.
| |
Looking for something different?
Find a wealth of reports, white papers, and other behavioral health and social service resources
in the OPEN MINDS Circle Library.
 To download the file in PDF format, you first need to download the free Adobe Acrobat Viewer. The Acrobat Viewer will launch
the file so that you can see the document and/or print it.
Download
Adobe Acrobat. | |
